Australia markets closed

MicroStrategy Incorporated (MSTR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
460.42-7.86 (-1.68%)
At close: 04:00PM EST
460.25 -0.17 (-0.04%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close468.28
Open482.79
Bid0.00 x 1300
Ask0.00 x 1000
Day's range458.46 - 491.99
52-week range411.58 - 1,315.00
Volume422,425
Avg. volume468,824
Market cap5.164B
Beta (5Y monthly)1.54
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    MicroStrategy Announces Earnings Release Date and Live Video Webinar for Fourth Quarter 2021 Financial Results

    TYSONS CORNER, Va., January 18, 2022--MicroStrategy® (Nasdaq: MSTR), the largest independent publicly-traded business intelligence company, today announced it will report its financial results for the fourth quarter of 2021 after the U.S. financial markets close on Tuesday, February 1, 2022. MicroStrategy will host a live Video Webinar on Tuesday, February 1, 2022 at 5:00 p.m. Eastern Time to discuss the company’s fourth quarter 2021 financial results. A live Video Webinar of the event can be ac

  • PR Newswire

    Cardinality.ai low code platform to deliver embedded AI and Intelligence at scale with MicroStrategy

    Cardinality.ai, a data technology group helping government agencies achieve better outcomes through artificial intelligence (AI) solutions announced a new OEM partnership with MicroStrategy (Nasdaq: MSTR). As a leading worldwide provider of enterprise analytics, MicroStrategy will deliver AI powered insights to Citizens, Caseworkers, and Policy leaders at scale.

  • PR Newswire

    Pfizer Drives Cultural Change in Sustainable and Accessible Data with MicroStrategy

    MicroStrategy, the US-based enterprise analytics platform, supported Pfizer, an American multinational pharmaceutical and biotechnology corporation, to usher in a future of sustainable data culture. With the help of solutions and tools designed to elevate the data game, Pfizer has seen the value of this inevitable change and continues to drive the conversation internally and externally.